Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Madeleine

Showing results (21-30 of 94) with videos related to

Pageof 10
Sort By:
AIDS (London, England)|December 31, 2008
Epidemiology of nonkeratinocytic skin cancers among persons with AIDS in the United StatesEmilie Lanoy, Graça M Dores, Margaret M Madeleine, et al.
Journal of Lower Genital Tract Disease|May 26, 2016
Natural Antibodies to Human Papillomavirus 16 and Recurrence of Vulvar High-Grade Intraepithelial Neoplasia (VIN3)Margaret M Madeleine, Lisa G Johnson, David R Doody, et al.
Preventive Medicine|August 3, 2021
Time and geographic variations in human papillomavirus vaccine uptake in Washington stateNastaran Pourebrahim, Parth Shah, Trang VoPham, et al.
Gynecologic Oncology|December 3, 2011
Genetic variation in CD83 and risks of cervical and vulvar cancers: a population-based case-control studyClara Bodelon, Margaret M Madeleine, Lisa G Johnson, et al.
International Journal of Molecular Epidemiology and Genetics|December 10, 2013
Common sequence variants in chemokine-related genes and risk of breast cancer in post-menopausal womenClara Bodelon, Katheleen E Malone, Lisa G Johnson, et al.
Journal of Virology|April 28, 2006
Identification of human papillomavirus type 16 L1 surface loops required for neutralization by human seraJoseph J Carter, Greg C Wipf, Margaret M Madeleine, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 13, 2010
Risk of cervical cancer associated with allergies and polymorphisms in genes in the chromosome 5 cytokine clusterLisa G Johnson, Stephen M Schwartz, Mari Malkki, et al.
Breast Cancer Research and Treatment|April 28, 2011
Genetic variation in proinflammatory cytokines IL6, IL6R, TNF-region, and TNFRSF1A and risk of breast cancerMargaret M Madeleine, Lisa G Johnson, Mari Malkki, et al.
BMC Cancer|May 3, 2013
Genetic variation in TLR or NFkappaB pathways and the risk of breast cancer: a case-control studyAlexa J Resler, Kathleen E Malone, Lisa G Johnson, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 20, 1999
CYP2D6 genotype and the incidence of anal and vulvar cancerC Chen, L S Cook, X Y Li, et al.
Pageof 10

Showing results (21-30 of 94) with videos related to

Sort By:
Pageof 10
AIDS (London, England)|December 31, 2008
Epidemiology of nonkeratinocytic skin cancers among persons with AIDS in the United StatesEmilie Lanoy, Graça M Dores, Margaret M Madeleine, et al.
Journal of Lower Genital Tract Disease|May 26, 2016
Natural Antibodies to Human Papillomavirus 16 and Recurrence of Vulvar High-Grade Intraepithelial Neoplasia (VIN3)Margaret M Madeleine, Lisa G Johnson, David R Doody, et al.
Preventive Medicine|August 3, 2021
Time and geographic variations in human papillomavirus vaccine uptake in Washington stateNastaran Pourebrahim, Parth Shah, Trang VoPham, et al.
Gynecologic Oncology|December 3, 2011
Genetic variation in CD83 and risks of cervical and vulvar cancers: a population-based case-control studyClara Bodelon, Margaret M Madeleine, Lisa G Johnson, et al.
International Journal of Molecular Epidemiology and Genetics|December 10, 2013
Common sequence variants in chemokine-related genes and risk of breast cancer in post-menopausal womenClara Bodelon, Katheleen E Malone, Lisa G Johnson, et al.
Journal of Virology|April 28, 2006
Identification of human papillomavirus type 16 L1 surface loops required for neutralization by human seraJoseph J Carter, Greg C Wipf, Margaret M Madeleine, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 13, 2010
Risk of cervical cancer associated with allergies and polymorphisms in genes in the chromosome 5 cytokine clusterLisa G Johnson, Stephen M Schwartz, Mari Malkki, et al.
Breast Cancer Research and Treatment|April 28, 2011
Genetic variation in proinflammatory cytokines IL6, IL6R, TNF-region, and TNFRSF1A and risk of breast cancerMargaret M Madeleine, Lisa G Johnson, Mari Malkki, et al.
BMC Cancer|May 3, 2013
Genetic variation in TLR or NFkappaB pathways and the risk of breast cancer: a case-control studyAlexa J Resler, Kathleen E Malone, Lisa G Johnson, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 20, 1999
CYP2D6 genotype and the incidence of anal and vulvar cancerC Chen, L S Cook, X Y Li, et al.
Pageof 10